Artelo Biosciences

Artelo Biosciences

Clinical-stage biopharmaceutical company (Nasdaq: ARTL)

Sobre Artelo Biosciences

Fundada

2017

Comunidade

Artelo Biosciences Inc. (Nasdaq: ARTL) is a clinical-stage biopharmaceutical company focused on developing therapeutics that modulate lipid signaling pathways. The company's pipeline includes drug candidates targeting pain, inflammation, anxiety, and cancer-related conditions. The company is utilizing clinical trials to validate their safety and efficacy, and utilizes an outsourced model for both R&D and manufacturing management.